Abstract:Objective The investigation aimed at producing transgenic mouse model with myocardium-specific overex-pression of human KCNE4 (hKCNE4) gene so as to research into the prophylactic and therapeutic effect of hKCNE4 gene on a certain subset of atrial fibrillation. Methods hKCNE 4 gene was cloned by reverse transcription-polymerase chain reaction (RT-PCR), digested with restrictive endonuclease, and inserted into the cardiomyocyte-specific expressing plasmidα-MHC-Clone 26 by ligase. Enzymatic and sequencing analyses were performed to confirm hKCNE4-α-MHC-Clone 26 prior to obtaining the BamHI treated transgenic element hKCNE4-α-MHC-hGH pA. The hKCNE4-α-MHC-hGH pA was microinjected into the male pronucleus of fertilized oocyte of C57BL mice and the oocytes surviving microin-jection were transplanted into the oviducts of pseudo-pregnant mice. The positive transgenic founder (G0 generation) mice were identified by PCR from offspring generated by pseudo-pregnant mice. The G0 transgenic mice were mated respectively with wild-type C57BL mice to reproduce G1 transgenic progeny. RT-PCR and sequencing were applied to screening for transgenic mice expressing hKCNE4 from G1 transgenic descendants. Results hKCNE4 gene was cloned and ligated to the vectorα-MHC-Clone 26 correctly. 86 mice were generated 9 of which were identified to be transgenic and the trans-gene hKCNE 4 carried by 2 transgenic mice (titled as Line A and Line B respectively) was not only transmitted to the next generation but also overexpressed restrictedly in the hearts. Preliminary phenotypic analysis on the transgenic progeny of Line A and Line B showed that they developed normally, reproduced generally, and suffered from no arrhythmia documented by surface electrocardiography. Conclusion The results indicate that the transgenic mice cardiomyocyte-specifically overexpressing hKCNE 4 are successfully procured, which provides a valuable tool for the exploration of the preventive and remedial influence of hKCNE 4 on a subgroup of atrial fibrillation.

Genetically Modified Rabbits for Cardiovascular Research

Rabbit models for the study of human atherosclerosis: From pathophysiological mechanisms to translational medicine

Genome-edited Rabbits: Unleashing the Potential of a Promising Experimental Animal Model Across Diverse Diseases

Gene Editing in Rabbits: Unique Opportunities for Translational Biomedical Research

Genomic and Transcriptomic Analysis of Hypercholesterolemic Rabbits: Progress and Perspectives

General Topic: Applications of Transgenic Rabbits in Biomedical Research - Based on Literature Search

Generation of Hyperlipidemic Rabbit Models Using Multiple Sgrnas Targeted CRISPR/Cas9 Gene Editing System

The Method for Creating Transgenic Rabbits

Hyperlipidemia-associated Gene Variations and Expression Patterns Revealed by Whole-Genome and Transcriptome Sequencing of Rabbit Models

Use of Rabbit Models to Study Atherosclerosis.

Small Mammalian Animal Models of Heart Disease.

Genome-edited Rabbit, a Prospective Alternative Model for Neurological Diseases

Research('s) Sweet Hearts: Experimental Biomedical Models of Diabetic Cardiomyopathy

Generation of hypoxanthine phosphoribosyltransferase gene knockout rabbits by homologous recombination and gene trapping through somatic cell nuclear transfer

Animal Models for Cardiovascular Research

Generation of Transgenic Mice for Cardiovascular Research.

ApoE knockout rabbits: A novel model for the study of human hyperlipidemia

Generation of knockout rabbits using transcription activator-like effector nucleases.

Modeling of Transgenic Mice Cardiac- Specifically Overexpressing Human KCNE4 Gene

Why choose the rabbit to work in reproductive technology?

Current Progress and Prospects in Rabbit Cloning